Cesarina Giallongo

Catania, 95123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP-SMAD Signaling to Therapeutic Modulation.

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP-SMAD Signaling to Therapeutic Modulation.

Journal: Biomolecules

Published: May 29, 2026

Pistachio Leaf Extract Modulates Redox-Dependent Mitochondrial and Metabolic Responses in Ethanol-Stressed HepG2 Cells.

Pistachio Leaf Extract Modulates Redox-Dependent Mitochondrial and Metabolic Responses in Ethanol-Stressed HepG2 Cells.

Journal: International journal of molecular sciences

Published: April 27, 2026

Long-Read RNA Sequencing Reveals an Isoform Switching Pattern in Healthy Microglial Cell Lines Exposed to Radiotherapy.

Long-Read RNA Sequencing Reveals an Isoform Switching Pattern in Healthy Microglial Cell Lines Exposed to Radiotherapy.

Journal: Non-coding RNA

Published: April 23, 2026

Heme oxygenase-1/CO signaling suppresses NLRP3 inflammasome-mediated stromal fibrosis in primary myelofibrosis.

Heme oxygenase-1/CO signaling suppresses NLRP3 inflammasome-mediated stromal fibrosis in primary myelofibrosis.

Journal: Free radical biology & medicine

Published: November 26, 2025

Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment.

Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment.

Journal: Discover oncology

Published: November 25, 2025

Glutamate accumulation in myelofibrosis microenvironment rewires mesenchymal stromal cells metabolic and epigenetic profiles.

Glutamate accumulation in myelofibrosis microenvironment rewires mesenchymal stromal cells metabolic and epigenetic profiles.

Journal: Cell communication and signaling : CCS

Published: September 17, 2025

Prothrombotic profiles in myelofibrosis: Fibrinogen oxidation and the beneficial effects of ruxolitinib.

Prothrombotic profiles in myelofibrosis: Fibrinogen oxidation and the beneficial effects of ruxolitinib.

Journal: Thrombosis research

Published: July 21, 2025

DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.

DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.

Journal: Blood

Published: June 11, 2025

Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG.

Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG.

Journal: Scientific reports

Published: February 28, 2025

Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma.

Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma.

Journal: Haematologica

Published: February 14, 2025

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment.

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment.

Journal: Cell death & disease

Published: January 07, 2025

Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.

Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.

Journal: Vaccines

Published: November 15, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026